Safety and Efficacy of Fingolimod in Pediatric Patients With Multiple Sclerosis
Clinical trial NCT01892722 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT01892722
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-26
- Primary completion
- 2017-07-14
- Enrollment
- 240
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.